• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3486 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2025     WorkSafeBC Firefighting and coronary heart disease
2025     WorkSafeBC CRPS and dental pain/sensitivity
2025     WorkSafeBC Traumatic brain injury (TBI) without any ocular trauma and cataract development
2025     WorkSafeBC Pulsed electromagnetic field therapy (PEMF), hyperbaric chamber, or acupuncture for treatment of hypersensitivity pneumonitis
2025     WorkSafeBC Meniscal injury and time to TKA: partial meniscectomy vs. conservative treatment
2025     WorkSafeBC Industrial instrument mechanic and development of multiple myeloma
2025     WorkSafeBC The effects of Sb2O3 [antimony trioxide] on human health
2025     WorkSafeBC Tower crane operators and low back pain
2025     WorkSafeBC Firefighting and Crohn’s disease
2025     WorkSafeBC Aerolase® System in treating burn/scar tissue
2025     WorkSafeBC IV ketamine therapy for long Covid
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Regulation and clinical prioritization processes for the optimal deployment of a helicopter emergency medical transport system in Quebec]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Antibiotic prophylaxis in digestive tract and abdominal wall surgery]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of prescription opioids for pain in Quebecers aged 65 years and older]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Artificial intelligence in medical imaging: fields of application and considerations for its deployment in Quebec]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [RT-qPCR monitoring of NPM1 variants for measurable residual disease in acute myeloid leukemia]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Relevance of the use of HIV rapid test kits by community workers in Québec]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Principles and criteria to guide the use of whole-genome sequencing versus targeted gene sequencing for the detection of somatic variants in oncology]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Next-generation medical devices: the rise of artificial intelligence]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Cardiac ultrasound: current practices]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Blood determination of N-terminal propeptide of procollagen type 1 (P1NP) by electrochemiluminescence immunoassay (ECLIA)]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Naloxone hydrochloride kits - stability and storage]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Treatment of migraine in adults]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Lipedema]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Presumed penicillin allergies: risk assessment for optimal and safe use of betalactams]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [External beam radiotherapy delivered by ultra-hypofractionation for the treatment of prostate cancer]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Relevance of adding screening for vitamin D-dependent rickets to the Quebec Neonatal Blood Screening Program]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec: patient characteristics, care trajectories and clinical outcomes, 2017 to 2023]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Mobile applications for pulmonary rehabilitation - chronic obstructive pulmonary disease]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Pentobarbital blood determination by HPLC-MS/MS]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Fetal sex determination using circulating cell-free DNA in cases of genetic risk: repatriation of an analysis carried out outside the province of Quebec]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Access to breast cancer screening for Québec women aged 40 to 49: issues, considerations and implementation approach]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview – Quebec frequent emergency department users 2022-2023]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of service use to address the medical needs of seniors receiving home care]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Tumor biomarkers related to the management of advanced cutaneous melanoma]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Proton pump inhibitors: deprescription and lifestyle changes]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of applications of extended reality technologies in health and social services]
2025     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Clinical follow-up of incidental pulmonary nodules: progress report on the selection of efficacy and safety indicators]
2025     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Cardiac and pulmonary telerehabilitation]
2025     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Use of the OxyGo NEXT® Portable Oxygen Concentrator during sleep: clinical effectiveness and safety]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Neurocognitive disorders: an adapted path from identification to treatment]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Technological innovations for the identification and diagnosis of neurocognitive disorders in Quebec]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Perinatal pathway: supporting women in a handicap situation related to a physical disability, an intellectual disability or autism]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Initiating a diagnostic and therapeutic measure in a person with signs and symptoms of pharyngitis/tonsillitis]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Fluoroscopic or endoscopic evaluation of dysphagia in adults]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Best group interventions for perpetrators of intimate partner violence]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Diabetic foot infection in adults: optimal use of antibiotic therapy and measures to prevent recurrence]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Microinvasive surgical (MIGS) devices and procedures for the treatment of moderate to severe glaucoma]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Multi-gene expression profiling tests to assess recurrence risk in early-stage breast cancer patients]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Idiopathic scoliosis: digital solutions for detection, diagnosis, and monitoring in children and adolescents]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Polymalformative syndromes next-generation sequencing (NGS) panel – repatriation of an analysis carried out outside of the province of Québec]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Parenteral ketamine for treatment-resistant depression in adults: clinical relevance, issues and framework]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Detection of vancomycin-resistant enterococci (VRE)]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Tumor biomarkers related to the management of people with breast cancer]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Adjustment of lipid-lowering agents (statins and ezetimibe) in the management of cardiovascular risk]
2025     Institute of Health Economics (IHE) PET/CT capacity for cancer diagnosis and follow-up: rapid review
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Blood levels testing of imatinib and its active metabolite by high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS)]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Food allergen-specific IgG4 (immunoglobulin G4) measurement by immunoassay]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [International experiences in home hospitalization: challenges and possible solutions]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [A look at connected objects and their integration into remote monitoring]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Prevention of hypersensitivity reactions to intravascular contrast media during medical imaging in adults]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Algorithm for the management of low back pain with or without radicular pain]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Non-pharmacological interventions, other than psychosocial ones, for youth aged under 18 with attention deficit/hyperactivity disorder (ADHD)]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Pharmacological treatment of migraine]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Relevance of adding vitamin-dependent rickets screening to neonatal screening]
2025     Technology Assessment at SickKids (TASK) A micro-costing and cost consequence analysis from a randomized controlled trial comparing genome sequencing to exome sequencing for genetic diagnosis
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Hospital at home in Québec healthcare institutions: considerations to support program implementation]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [New drug treatments for Alzheimer's disease: considerations for patient management]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Treatment of mitral insufficiency with a percutaneous device with clip (TEER) in Quebec - characteristics, continuum of care and clinical outcomes of adult clientele treated between 2019-2020 and 2021-2022]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Tumor biomarkers related to the management of bladder cancer patients]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Fibrin sealants and hemostatic matrices in an intraoperative context]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Blood testing for cystatin C by immunoturbidimetry]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Buccal cell sampling as a source of genetic material]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Appropriate use of cardiac monitoring in the emergency department]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Bispecific and tumor-infiltrating T cell therapies: considerations for deployment in Quebec]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Effectiveness and safety of scalp cooling to prevent chemotherapy-induced alopecia (CIA)]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Confirmed trichomonas vaginalis infection: pharmacological treatment]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Lung cancer treatment algorithm]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Breast cancer treatment algorithm]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Tumor biomarkers related to managing people with prostate cancer]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Tumor biomarkers related to managing people with cervical cancer]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Microinvasive glaucoma surgery (MIGS) - Hydrus Microstent for the treatment of mild to moderate glaucoma]
2024     Ontario Health Robotic-assisted surgery for rectal cancer: an expedited summary of the clinical evidence
2024     Institute of Health Economics (IHE) Sacral nerve stimulation for the treatment of fecal incontinence
2024     Institute of Health Economics (IHE) Integrating non-physician assessors into the healthcare system for assessment of musculoskeletal conditions
2024     WorkSafeBC Natural gas odorants and miscarriage
2024     WorkSafeBC Compartment syndrome and collagen structure
2024     WorkSafeBC Risk factors associated with the development or acceleration of degenerative disc disease for helicopter pilots - 2024 update
2024     WorkSafeBC Low-dose naltrexone as treatment for post-Covid conditions: first update
2024     WorkSafeBC COVID-19 and multiple sclerosis relapse
2024     WorkSafeBC Best practices for preventing psychological injury to front-line community support workers
2024     WorkSafeBC Restless legs syndrome (RLS) and post-traumatic stress disorder (PTSD): 2024 update
2024     WorkSafeBC Dance movement therapy as treatment for post-traumatic stress disorder (PTSD)
2024     WorkSafeBC Causal association on the development of transverse myelitis post mRNA Covid-19 vaccination
2024     WorkSafeBC Colon cancer and firefighting
2024     WorkSafeBC Causal association of neuroendocrine tumors and work duties as a firefighter
2024     WorkSafeBC Pharmacological and psychosocial interventions for ketamine use disorder
2024     WorkSafeBC Efficacy/effectiveness of prolozone or PEMF in treating shoulder or back strain as well as disc herniation
2024     WorkSafeBC Causal association between exposure to certain chemicals and the development of idiopathic Parkinson's Disease
2024     WorkSafeBC Causal association of being a retired firefighter and the development of coronary artery diseases (CAD)